United States · FDA National Drug Code directory
Sirolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-746_b6349068-caf8-4f40-959d-cb9f1b8dd2be
- Product NDC
- 67877-746
- Form
- TABLET, FILM COATED
- Composition / generic term
- Sirolimus
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210313
- Source listing expiry
- 20261231
Source-listed ingredients
- SIROLIMUS — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (67877-746-01) · 67877-746-01
- 500 TABLET, FILM COATED in 1 BOTTLE (67877-746-05) · 67877-746-05
- 30 TABLET, FILM COATED in 1 BOTTLE (67877-746-30) · 67877-746-30
- 100 BLISTER PACK in 1 CARTON (67877-746-38) / 10 TABLET, FILM COATED in 1 BLISTER PACK (67877-746-33) · 67877-746-38
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →